PA
REAX icon

PharVision Advisers’s Real Brokerage REAX Stock Holding History

PharVision Advisers’s Portfolio REAX Stock Details REAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.5K Sell
20,985
-77,499
-79% -$234K 0.53% 87
2025
Q4 		$359K Buy
98,484
+38,893
+65% +$150K 0.18% 170
2025
Q3 		$249K Buy
+59,591
New +$269K 0.14% 333

Other funds holding REAX

MVPGP
Magma Venture Partners General Partner Tel Aviv, Israel $59.2M AUM 38.42% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's REAX Position: Q1 2026 in Review

PharVision Advisers reduced its Real Brokerage (REAX) stake by 79% in Q1 2026, selling an estimated $234K and leaving 20,985 shares worth $52.5K. The position accounts for 0.53% of the portfolio, ranked #87.

PharVision Advisers first reported a position in REAX in Q3 2025 and has held it in 3 quarters since. The position peaked at $359K in Q4 2025. 159 funds tracked by Wall St. Rank hold REAX as of Q1 2026.

  • PharVision Advisers held 20,985 shares of Real Brokerage worth $52.5K as of Q1 2026.
  • PharVision Advisers sold 77,499 Real Brokerage shares in Q1 2026, an estimated $234K.
  • Real Brokerage made up 0.53% of PharVision Advisers's portfolio in Q1 2026, its #87 holding.
  • PharVision Advisers first reported a position in Real Brokerage in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's Real Brokerage position peaked at $359K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Real Brokerage as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.